ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ALEC vs IRLA // ENTERPRISE SCALE & MARKET CAP

Alector Inc. (NASDAQ) VS. IRulya Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: ALEC 2 — IRLA 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: IRLA
market-cap
$332.1M
market-cap
$342.8M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALEC VS. IRLA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ALEC IRLA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -12.19% — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -65.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 1/9 +1.00 ALEC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.4 52.5 +7.88 ALEC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $332.1M $342.8M -$10.7M IRLA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ALEC REV IRLA REV ALEC GROSS % IRLA GROSS % ALEC FCF IRLA FCF
FY 2025 $21.0M $0 — — -$184.1M -$41.8M
FY 2024 $100.6M $0 — — -$231.2M -$32.2M
FY 2023 $97.1M $0 — — -$184.2M -$18.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALEC // BETA —
IRLA // BETA —